Brief: Petros Pharmaceuticals Assigns All Assets To Pt Liquidation, For Benefit Of Creditors
30/09/2026 23:33
BRIEF-Petros Pharmaceuticals Assigns All Assets To Pt Liquidation, For Benefit Of Creditors Oct 1 (Reuters) - Petros Pharmaceuticals Inc PTPI.PK:
PETROS PHARMACEUTICALS - ASSIGNS ALL ASSETS TO PT LIQUIDATION, FOR BENEFIT OF CREDITORS - SEC FILING
PETROS PHARMACEUTICALS - CEASES SUBSTANTIALLY ALL BUSINESS OPERATIONS - SEC FILING
PETROS PHARMACEUTICALS - ALL OUTSTANDING OBLIGATIONS MAY BE IMMEDIATELY DUE; SERIES A CONVERTIBLE PREFERRED STOCK TO BE REDEEMED - SEC FILING
Further company coverage: PTPI.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Petros Pharmaceuticals
See all newsBrief: Petros Pharmaceuticals Assigns All Assets To Pt Liquidation, For Benefit Of Creditors
Brief: Petros Pharmaceuticals’ STENDRA Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
Brief: Petros Pharmaceuticals Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: Petros Pharmaceuticals Expands Online Distribution For Prescription STENDRA(R) Through New Agreement With Lemonaid Health
Brief: Petros Pharma Announces Partnership with Idea Evolver for Rx-to-OTC Switches & Digital Launch Solutions